[New Aspects of Stroke Medicine]

Overview

Journal Nervenarzt

Specialty Neurology

Date 2014 Jun 28

PMID 24969949

Authors

H C Diener

B Frank

K Hajjar

C Weimar

Affiliations

Soon will be listed here.

Abstract

Systemic thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) remains the only effective and approved medical treatment of acute ischemic stroke. Several studies have demonstrated the importance of rapid recanalization. The efficacy of thrombectomy has so far not been sufficiently shown in randomized clinical trials; therefore, inclusion of suitable patients in one of the currently ongoing randomized trials is of great importance. The early treatment with magnesium after acute ischemic stroke during the pre-hospital phase did not prove to be neuroprotective. Intermittent pneumatic compression of the lower extremities in immobilized stroke patients effectively prevents deep venous thrombosis and pulmonary embolism. In patients with lacunar stroke the combination of aspirin and clopidogrel is not superior to aspirin alone and causes more bleeding complications. The novel oral anticoagulants are superior to warfarin in secondary prevention and carry a lower risk of intracranial and systemic bleeding complications. New studies will investigate whether dabigatran or rivaroxaban are superior to aspirin in secondary prevention after cryptogenic stroke.

References

Xian Y, Liang L, Smith E, Schwamm L, Reeves M, Olson D . Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA. 2012; 307(24):2600-8. DOI: 10.1001/jama.2012.6756. View

Hart R, Diener H, Coutts S, Easton J, Granger C, ODonnell M . Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4):429-38. DOI: 10.1016/S1474-4422(13)70310-7. View

Mendelow A, Gregson B, Fernandes H, Murray G, Teasdale G, Hope D . Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005; 365(9457):387-97. DOI: 10.1016/S0140-6736(05)17826-X. View

Ding M, Bhupathiraju S, Satija A, van Dam R, Hu F . Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2013; 129(6):643-59. PMC: 3945962. DOI: 10.1161/CIRCULATIONAHA.113.005925. View

Benavente O, Hart R, McClure L, Szychowski J, Coffey C, Pearce L . Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012; 367(9):817-25. PMC: 4067036. DOI: 10.1056/NEJMoa1204133. View

Chen G, Lu D, Pang Z, Liu Q . Vitamin C intake, circulating vitamin C and risk of stroke: a meta-analysis of prospective studies. J Am Heart Assoc. 2013; 2(6):e000329. PMC: 3886767. DOI: 10.1161/JAHA.113.000329. View

Hankey G . Secondary stroke prevention. Lancet Neurol. 2013; 13(2):178-94. DOI: 10.1016/S1474-4422(13)70255-2. View

Lees K, Bluhmki E, von Kummer R, Brott T, Toni D, Grotta J . Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010; 375(9727):1695-703. DOI: 10.1016/S0140-6736(10)60491-6. View

Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg P, Kaste M . Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012; 79(4):306-13. DOI: 10.1212/WNL.0b013e31825d6011. View

10.

Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C . Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013; 369(1):11-9. DOI: 10.1056/NEJMoa1215340. View

11.

Majeed A, Schulman S . Bleeding and antidotes in new oral anticoagulants. Best Pract Res Clin Haematol. 2013; 26(2):191-202. DOI: 10.1016/j.beha.2013.07.001. View

12.

Mendelow A, Gregson B, Rowan E, Murray G, Gholkar A, Mitchell P . Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet. 2013; 382(9890):397-408. PMC: 3906609. DOI: 10.1016/S0140-6736(13)60986-1. View

13.

Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Marti-Fabregas J . Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol. 2014; 13(5):453-60. DOI: 10.1016/S1474-4422(14)70054-7. View

14.

Majeed A, Hwang H, Connolly S, Eikelboom J, Ezekowitz M, Wallentin L . Management and outcomes of major bleeding during treatment with dabigatran or warfarin. Circulation. 2013; 128(21):2325-32. DOI: 10.1161/CIRCULATIONAHA.113.002332. View

15.

Benavente O, White C, Pearce L, Pergola P, Roldan A, Benavente M . The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke. 2011; 6(2):164-75. PMC: 4214141. DOI: 10.1111/j.1747-4949.2010.00573.x. View

16.

Cote R, Zhang Y, Hart R, McClure L, Anderson D, Talbert R . ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection?. Neurology. 2014; 82(5):382-9. PMC: 3917683. DOI: 10.1212/WNL.0000000000000076. View

17.

Estruch R, Ros E, Salas-Salvado J, Covas M, Corella D, Aros F . Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013; 368(14):1279-90. DOI: 10.1056/NEJMoa1200303. View

18.

Kidwell C, Jahan R, Gornbein J, Alger J, Nenov V, Ajani Z . A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013; 368(10):914-23. PMC: 3690785. DOI: 10.1056/NEJMoa1212793. View

19.

Saver J, Fonarow G, Smith E, Reeves M, Grau-Sepulveda M, Pan W . Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013; 309(23):2480-8. DOI: 10.1001/jama.2013.6959. View

20.

Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R . Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013; 368(10):904-13. PMC: 3708480. DOI: 10.1056/NEJMoa1213701. View